Skye Bioscience, Inc. · NASDAQ:SKYE
Schwab Andrew J. sold 148,079 Skye Bioscience, Inc. shares (Form 4)
Traded Sep 22 to Sep 23, 2026 · Filed Sep 24, 2026
From Sep 22 to Sep 23, 2026, Schwab Andrew J. (Director, 10% owner) sold 148,079 Skye Bioscience, Inc. shares at an average US$1.62 for US$240K, leaving 0 shares. Filed Sep 24, 2026 (Form 4).
- Sold
- 148,079 shares
- Price
- US$1.62 average (US$1.61 to US$1.65)
- Value
- US$240K
- Holding after
- 0 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | Common Stock | Sale | 27,612 | US$1.65 | 114,851 | Indirect |
| Sep 22, 2026 | Common Stock | Sale | 1,088 | US$1.65 | 4,528 | Indirect |
| Sep 23, 2026 | Common Stock | Sale | 114,851 | US$1.61 | 0 | Indirect |
| Sep 23, 2026 | Common Stock | Sale | 4,528 | US$1.61 | 0 | Indirect |
Source
Related
- Skye Bioscience, Inc.
- Schwab Andrew J.
- Skye Bioscience, Inc. shareholders
- Form 4 · Schwab Andrew J. · Sep 18, 2026
- Form 4 · Schwab Andrew J. · Aug 20, 2026
- Form 4 · 5AM Ventures II LP · Sep 24, 2026
- Form 4 · Parmar Kush · Sep 18, 2026
- Form 4 · 5AM Partners II, LLC · Aug 20, 2026
- Schedule 13D/A · Schwab Andrew J. · Aug 18, 2026
- Form 4 · Dhillon Punit · Aug 7, 2026